Day One Biopharmaceutical...

NASDAQ: DAWN · Real-Time Price · USD
6.76
0.51 (8.16%)
At close: Aug 15, 2025, 3:59 PM
6.75
-0.15%
After-hours: Aug 15, 2025, 06:48 PM EDT

Day One Biopharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
124.97M 230.78M 85.26M 284.31M
Short-Term Investments
406.75M 135.56M 257.01M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
121K 214K 469K 169K
Receivables
13.88M n/a n/a n/a
Inventory
3.32M n/a n/a n/a
Other Current Assets
4.37M 2.35M 1.01M 1.01M
Total Current Assets
562.33M 375.27M 347.87M 289.37M
Property-Plant & Equipment
4.71M 560K 719K 284K
Goodwill & Intangibles
15.63M n/a n/a n/a
Total Long-Term Assets
20.46M 774K 1.19M 453K
Total Assets
582.79M 376.05M 349.06M 289.82M
Account Payables
3.26M 2.58M 260K 1.74M
Deferred Revenue
1.55M n/a n/a 6.61M
Short-Term Debt
10K n/a 405K 204K
Other Current Liabilities
68.61M 1.04M 9.42M -100K
Total Current Liabilities
73.45M 29.51M 16.61M 8.66M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
761K n/a n/a n/a
Total Long-Term Liabilities
6.59M n/a 408K 16K
Total Liabilities
80.04M 29.51M 17.02M 8.67M
Total Debt
2.6M 408K 813K 220K
Common Stock
10K 9K 7K 6K
Retained Earnings
-554.08M -458.58M -269.67M -127.49M
Comprehensive Income
84K 9K -71K 0.00
Shareholders Equity
502.75M 346.54M -269.67M -127.49M
Total Investments
406.75M 135.56M 257.01M n/a